Open Payments

Sutter Davis Hospital

Type
Teaching hospital
Where
Davis, CA
Medicare CCN
050537
Received
$126,376 in 35 records, 2025 ($78 general, $126,297 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment3$78
2025Research payment32$126,297

By company

CompanyRecordsAmountYears
PFIZER INC.8$45,1332025
Abbott Laboratories10$41,9892025
Genentech, Inc.2$17,3672025
Ethicon Endo-Surgery Inc.6$15,5502025
BioMarin Pharmaceutical Inc.1$3,9992025
MEDIVATION LLC.5$2,2582025
Bio-Rad Laboratories, Inc.3$782025

By nature of payment

NatureRecordsAmount
Research payment32$126,297
Debt forgiveness3$78

Records

DateCompanyAmountNatureFormProductStudyYear
2025-12-31PFIZER INC.$4,754Research paymentCash or cash equivalentAN INTERVENTIONAL OPENLABEL RANDOMIZED MULTICENTER PHASE 3 STUDY OF PF07220060 PLUS LETROZOLE COMPARED TO CDK46 INHIBITO2025
2025-12-27PFIZER INC.$4,779Research paymentCash or cash equivalentAN INTERVENTIONAL OPENLABEL RANDOMIZED MULTICENTER PHASE 3 STUDY OF PF07220060 PLUS LETROZOLE COMPARED TO CDK46 INHIBITO2025
2025-12-08PFIZER INC.$1,750Research paymentCash or cash equivalentXTANDI Drug, ONCOLOGYA RANDOMIZED PHASE II TRIAL OF SALVAGE RADIOTHERAPY WITH STANDARD VS ENHANCED ANDROGEN DEPRIVATION THERAPY WITH ENZALUTA2025
2025-12-01Ethicon Endo-Surgery Inc.$3,886Research paymentCash or cash equivalentNeuwave Device, Ablation SystemA Multi Center Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue2025
2025-11-26Abbott Laboratories$1,234Research paymentCash or cash equivalentMITRACLIP Device, Structural HeartNCT04198870--MitraClip REPAIR MR Study2025
2025-11-25PFIZER INC.$4,499Research paymentCash or cash equivalentAN INTERVENTIONAL OPENLABEL RANDOMIZED MULTICENTER PHASE 3 STUDY OF PF07220060 PLUS LETROZOLE COMPARED TO CDK46 INHIBITO2025
2025-11-05Abbott Laboratories$2,707Research paymentCash or cash equivalent Device, Structural HeartNCT03904147--TRILUMINATE Pivotal Trial2025
2025-10-27Abbott Laboratories$3,098Research paymentCash or cash equivalentCARDIOMEMS Device, Cardiac Rhythm ManagementNCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Hea2025
2025-10-27Abbott Laboratories$65Research paymentCash or cash equivalentCARDIOMEMS Device, Cardiac Rhythm ManagementNCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Hea2025
2025-10-01BioMarin Pharmaceutical Inc.$3,999Research paymentCash or cash equivalentVOXZOGO 1.2mg Drug, AchondroplasiaA Phase 2, Randomized, Controlled, Multicenter Study of Vosoritide in Children With Idiopathic Short Stature2025
2025-08-18Abbott Laboratories$5,645Research paymentCash or cash equivalentMITRACLIP Device, Structural HeartNCT04198870--MitraClip REPAIR MR Study2025
2025-08-11Abbott Laboratories$5,869Research paymentCash or cash equivalent Device, Structural HeartNCT03904147--TRILUMINATE Pivotal Trial2025
2025-08-08Ethicon Endo-Surgery Inc.$1,737Research paymentCash or cash equivalentNeuwave Device, Ablation SystemA Multi Center Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue2025
2025-06-26PFIZER INC.$17,500Research paymentCash or cash equivalentAN INTERVENTIONAL OPENLABEL RANDOMIZED MULTICENTER PHASE 3 STUDY OF PF07220060 PLUS LETROZOLE COMPARED TO CDK46 INHIBITO2025
2025-06-25Abbott Laboratories$6,368Research paymentCash or cash equivalentMITRACLIP Device, Structural HeartNCT04198870--MitraClip REPAIR MR Study2025
2025-06-09Genentech, Inc.$1,367Research paymentCash or cash equivalentHerceptin Biological, BioOncologyChemo trastuzumab vs chemo trastuzumab pertuzumab2025
2025-06-02MEDIVATION LLC.$250Research paymentCash or cash equivalentXTANDI Drug, ONCOLOGYA PHASE 3 RANDOMIZED EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE PLUS LEUPROLIDE ENZALUTAMIDE MONOTHERAPY AND PLACEBO PLUS2025
2025-06-02MEDIVATION LLC.$250Research paymentCash or cash equivalentXTANDI Drug, ONCOLOGYA PHASE 3 RANDOMIZED EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE PLUS LEUPROLIDE ENZALUTAMIDE MONOTHERAPY AND PLACEBO PLUS2025
2025-05-12Abbott Laboratories$4,474Research paymentCash or cash equivalent Device, Structural HeartNCT03904147--TRILUMINATE Pivotal Trial2025
2025-05-12Ethicon Endo-Surgery Inc.$307Research paymentCash or cash equivalentNeuwave Device, Ablation SystemA Multi Center Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue2025
2025-05-05MEDIVATION LLC.$586Research paymentCash or cash equivalentXTANDI Drug, ONCOLOGYA PHASE 3 RANDOMIZED EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE PLUS LEUPROLIDE ENZALUTAMIDE MONOTHERAPY AND PLACEBO PLUS2025
2025-05-05MEDIVATION LLC.$586Research paymentCash or cash equivalentXTANDI Drug, ONCOLOGYA PHASE 3 RANDOMIZED EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE PLUS LEUPROLIDE ENZALUTAMIDE MONOTHERAPY AND PLACEBO PLUS2025
2025-04-11Ethicon Endo-Surgery Inc.$579Research paymentCash or cash equivalentNeuwave Device, Ablation SystemA Multi Center Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue2025
2025-04-02PFIZER INC.$1,500Research paymentCash or cash equivalentPFIZER REGISTRY OF OUTCOMES IN GROWTH HORMONE RESEARCH PROGRES A MULTI COUNTRY NONINTERVENTIONAL PROSPECTIVE COHORT STUD2025
2025-03-17Abbott Laboratories$6,904Research paymentCash or cash equivalent Device, Structural HeartNCT03904147--TRILUMINATE Pivotal Trial2025
2025-03-10Ethicon Endo-Surgery Inc.$1,158Research paymentCash or cash equivalentNeuwave Device, Ablation SystemA Multi Center Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue2025
2025-03-03MEDIVATION LLC.$586Research paymentCash or cash equivalentXTANDI Drug, ONCOLOGYA PHASE 3 RANDOMIZED EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE PLUS LEUPROLIDE ENZALUTAMIDE MONOTHERAPY AND PLACEBO PLUS2025
2025-02-24Abbott Laboratories$5,621Research paymentCash or cash equivalentMITRACLIP Device, Structural HeartNCT04198870--MitraClip REPAIR MR Study2025
2025-02-06Ethicon Endo-Surgery Inc.$7,883Research paymentCash or cash equivalentNeuwave Device, Ablation SystemA Multi Center Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue2025
2025-02-04Genentech, Inc.$16,000Research paymentCash or cash equivalentGiredestrant CDKi of Choice in ESR1m Enriched 1L HR mBC Secondary Endocrine Resistant Patients2025
2025-02-03PFIZER INC.$10,000Research paymentCash or cash equivalentTHE COMPASSHER2 TRIALS COMPREHENSIVE USE OF PATHOLOGIC RESPONSE ASSESSMENT TO OPTIMIZE THERAPY IN HER2POSITIVE BREAST CA2025
2025-01-31PFIZER INC.$350Research paymentCash or cash equivalentXTANDI Drug, ONCOLOGYA RANDOMIZED PHASE II TRIAL OF SALVAGE RADIOTHERAPY WITH STANDARD VS ENHANCED ANDROGEN DEPRIVATION THERAPY WITH ENZALUTA2025
2025-01-09Bio-Rad Laboratories, Inc.$32Debt forgivenessCash or cash equivalentD10 Device, Diabetes2025
2025-01-09Bio-Rad Laboratories, Inc.$32Debt forgivenessCash or cash equivalentD-100 Device, Diabetes2025
2025-01-09Bio-Rad Laboratories, Inc.$13Debt forgivenessCash or cash equivalentD-100 Device, Diabetes2025

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Yolo CountyDavis city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Davis, CA, county Yolo County, CA, state California; placed by its city name.

MeasurePlace (city or town)
Davis, CA
County
Yolo County, CA
State
California
Population B0100366,978220,56439,287,377
Population, 2020 census P166,850216,40339,538,223
Median age B0100226.432.137.9
Under 18 B0100113.5%20.1%22.0%
65 and over B0100114.0%13.5%15.7%
Households B1100125,35876,69313,548,091
Foreign born B0500219.0%21.0%27.0%
Median household income B19013$90,045$91,752$99,122
Median family income B19113$169,957$122,185$113,346
Per capita income B19301$51,329$43,733$49,513
Poverty rate B1700126.5%16.7%12.0%
Unemployment rate B230256.3%6.1%6.6%
Civilian labor force B2302535,370111,26620,068,466
Mean commute (minutes) B0801322.324.028.7
Bachelor's degree or higher B1500376.8%44.8%37.1%
Housing units B2500127,48482,44714,644,735
Owner-occupied B2500343.5%54.3%55.9%
Renters B2500356.5%45.7%44.1%
Median home value B25077$866,100$620,700$734,700
Median gross rent B25064$2,187$1,857$2,036
White, not Hispanic B0300249.9%41.8%33.8%
Black B030022.2%2.4%5.2%
Hispanic or Latino B0300215.1%33.4%40.2%
Asian B0300224.2%14.9%15.3%
American Indian and Alaska Native B030020.2%0.4%0.3%

Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); Unemployment rate: 5.5% in Sep 2016 to 5.1% in Sep 2026; low 3.8%, high 16.1% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Davis, CA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.